On the morning of Saturday, Jan. 13, Wiley Chambers, MD, drove to his Center for Drug Evaluation and Research office at the FDA.
This was to be the last day of his extraordinary 36-year career at the FDA. He continued to work on pending reviews, cleaned his office, and took a few calls from those making last-minute pleas with the hope that he would stay on, at least for another year or two. On one of those calls, he reminded me that this was not the end of his life (Read more...)